Dudediligence.

TransMedics Group, Inc

TMDXNASDAQ · Electromedical & Electrotherapeutic Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$108.8MSep ’24$121.6MDec ’24$143.5MMar ’25$157.4MJun ’25$143.8MSep ’25$160.8MDec ’25$173.9MMar ’26$189.9MJun ’26
Net income, by quarter
$4.2MSep ’24$6.9MDec ’24$25.7MMar ’25$34.9MJun ’25$24.3MSep ’25$105.4MDec ’25$7.3MMar ’26$14.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$30.3M$93.5M$241.6M$441.5M$605.5M
Gross profit$21.2M$65.3M$154.1M$262.1M$362.8M
Operating income−$39.4M−$31.4M−$28.7M$37.5M$108.6M
Net income−$44.2M−$36.2M−$25.0M$35.5M$190.3M
Operating cash flow−$28.9M−$45.8M−$13.0M$48.8M$192.8M
Free cash flow−$32.4M−$57.7M−$164.9M−$80.9M$133.6M
Cash$26.1M$201.7M$395.3M$337.1M$488.9M
Debt$35.2M$58.7Mnone on filenone on file$10.0M
Shares outstanding27.8M32.1M32.7M33.6M34.3M